Price T Rowe Associates Inc Atri Cure, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 40,329 shares of ATRC stock, worth $1.44 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,329

Previous 39,858 1.18%

Holding current value

$1.44 Million

Previous $908,000 24.56%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$20.34 - $29.5 $9,580 - $13,894	471 Added 1.18%	40,329 $1.13 Million
Q2 2024 Aug 14, 2024	BUY	$19.86 - $29.09 $152,048 - $222,713	7,656 Added 23.77%	39,858 $908,000
Q1 2024 May 15, 2024	SELL	$28.21 - $37.78 $9.64 Million - $12.9 Million	-341,559 Reduced 91.38%	32,202 $980,000
Q4 2023 Feb 14, 2024	SELL	$32.99 - $43.25 $2 Million - $2.63 Million	-60,722 Reduced 13.98%	373,761 $13.3 Million
Q3 2023 Nov 14, 2023	SELL	$41.12 - $57.73 $48,110 - $67,544	-1,170 Reduced 0.27%	434,483 $19 Million
Q2 2023 Aug 14, 2023	BUY	$40.44 - $49.6 $8,209 - $10,068	203 Added 0.05%	435,653 $21.5 Million
Q1 2023 May 15, 2023	BUY	$35.87 - $47.22 $29,377 - $38,673	819 Added 0.19%	435,450 $18.1 Million
Q4 2022 Feb 14, 2023	BUY	$33.48 - $47.45 $85,407 - $121,044	2,551 Added 0.59%	434,631 $19.3 Million
Q3 2022 Nov 14, 2022	SELL	$38.25 - $52.62 $52.3 Million - $71.9 Million	-1,367,334 Reduced 75.99%	432,080 $16.9 Million
Q2 2022 Aug 15, 2022	SELL	$35.1 - $66.01 $2.98 Million - $5.6 Million	-84,857 Reduced 4.5%	1,799,414 $73.5 Million
Q1 2022 May 16, 2022	SELL	$57.43 - $71.39 $3.53 Million - $4.39 Million	-61,480 Reduced 3.16%	1,884,271 $124 Million
Q4 2021 Feb 14, 2022	SELL	$63.4 - $87.14 $4.49 Million - $6.16 Million	-70,745 Reduced 3.51%	1,945,751 $135 Million
Q3 2021 Nov 15, 2021	SELL	$69.28 - $84.46 $10.7 Million - $13.1 Million	-155,097 Reduced 7.14%	2,016,496 $140 Million
Q2 2021 Aug 16, 2021	SELL	$64.13 - $80.18 $6.03 Million - $7.54 Million	-94,035 Reduced 4.15%	2,171,593 $172 Million
Q1 2021 May 17, 2021	SELL	$53.79 - $66.98 $3.54 Million - $4.41 Million	-65,805 Reduced 2.82%	2,265,628 $148 Million
Q4 2020 Feb 16, 2021	BUY	$34.56 - $57.55 $80.6 Million - $134 Million	2,331,433 New	2,331,433 $130 Million

Others Institutions Holding ATRC

# of Institutions

212

Shares Held

49.7M

Call Options Held

12K

Put Options Held

7.2K

View Full List

About AtriCure, Inc.

Ticker ATRC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 46,424,700
Market Cap $1.66B
Description
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...

More about ATRC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Atri Cure, Inc. Transaction History